Psychosis-proneness correlates with expression levels of dopaminergic genes

European Psychiatry

Volumn 29, Issue 5, 2014, Pages 304-306

  Grant, P ^a   Gabriel, F ^a   Kuepper, Y ^a   Wielpuetz, C ^a   Hennig, J ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Endophenotype; Gene expression; Molecular biology; Psychosis proneness; Schizophrenia and psychosis; Schizotypy

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; PROTEIN FOS; RNA; AMINE OXIDASE (FLAVIN CONTAINING); COMT PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; DRD5 PROTEIN, HUMAN; PROTEIN V FOS;

ARTICLE; BRAIN TISSUE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSIS PRONENESS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; GENETICS;

CATECHOL O-METHYLTRANSFERASE; HUMANS; MALE; MONOAMINE OXIDASE; ONCOGENE PROTEINS V-FOS; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5;

EID: 84902368744     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2013.12.002     Document Type: Article

References (18)

1. Avramopoulos D., Stefanis N.C., Hantoumi I., Smyrnis N., Evdokimidis I., Stefanis C.N. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry 2002, 7(7):706-711. 10.1038/sj.mp.4001070.
2. Claridge G. Theoretical background and issues. Schizotypy - Implications for Illness and Health 1997, 3-18. Oxford University Press, Oxford, New York, Tokyo. 1st ed. G. Claridge (Ed.).
3. de Jong S., Boks M.P., Fuller T.F., Strengman E., Janson E., de Kovel C.G. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One 2012, 7(6):e39498. [doi:10.1371/journal.pone.0039498 PONE-D-11-16822 [pii]].
4. Ettinger U., Corr P.J., Mofidi A., Williams S.C., Kumari V. Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learning. Front Hum Neurosci 2013, 7:130. [doi:10.3389/fnhum.2013.00130].
5. Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A 2005, 102(43):15533-15538. [doi:0507666102 [pii]10.1073/pnas.0507666102].
6. Grant P. Letter to the Editor: haloperidol but not dopamine rapidly induces neuronal death: comments on "A systematic review of the effects of antipsychotic drugs on brain volume". Psychol Med 2013, 43(07):1568. [doi:S0033291713001001 [pii] 10.1017/S0033291713001001].
7. Grant P., Kuepper Y., Mueller E., Wielpuetz C., Mason O., Hennig J. Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) - a suitable endophenotype of schizophrenia. Front Hum Neurosci 2013, 7(1). [doi:10.3389/fnhum.2013.00001].
8. Grazioplene R.G., Chavez R.S., DeYoung C.G. Disconnected Minds, Open Minds: white matter correlates of high Openness support a dimensional model of psychosis. Paper presented at the ISSID 2013, Barcelona 2013.
9. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10(1):40-48. [image 45. doi:10.1038/sj.mp.4001558 4001558 [pii]].
10. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., Eberwine J.H. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 2002, 59(7):631-640. [doi:yoa20032 [pii]].
11. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III. The final common pathway. Schizophr Bull 2009, 35(3):549-562. [doi:10.1093/schbul/sbp006].
12. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006, 12(4):349-361. [doi:12/4/349 [pii] 10.1177/1073858406287536].
13. Lenzenweger M.F. Schizotypy - an organizing framework for schizophrenia research. Curr Dir Psychol Sci 2006, 15(4):162-166. [doi:10.1111/j.1467-8721.2006.00428.x].
14. Macare C., Woestmann N.M., Aichert D.S., Meindl T., Ettinger U. The Schizotypal Brain - An fMRI Antisaccade Task Study. Paper presented at the ISSID 2013, Barcelona 2013.
15. Mason O., Claridge G. The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophr Res 2006, 82(2-3):203-211. [doi:10.1016/j.schres.2005.12.845].
16. Maycox P.R., Kelly F., Taylor A., Bates S., Reid J., Logendra R. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009, 14(12):1083-1094. [doi: mp200918 [pii] 10.1038/mp.2009.18].
17. Sheldrick A.J., Krug A., Markov V., Leube D., Michel T.M., Zerres K. Effect of COMT val(158)met genotype on cognition and personality. Eur Psychiatry 2008, 23(6):385-389. 10.1016/j.eurpsy.2008.05.002.
18. Smyrnis N., Avramopoulos D., Evdokimidis I., Stefanis C.N., Tsekou H., Stefanis N.C. Effect of schizotypy on cognitive performance and its tuning by COMT val(158) met genotype variations in a large population of young men. Biol Psychiatry 2007, 61(7):845-853. 10.1016/j.biopsych.2006.07.019.